Miranda Schmalfuhs

Articles by Miranda Schmalfuhs

Pharma Pulse 9/6/24: Validating COAs, Simplified HIV Treatments Can Lead to Lower Healthcare Costs & more

ByMiranda Schmalfuhs

September 6th 2024

Pharma Pulse 9/5/24: FDA Wants Safer Cancer Drugs, Can Outcomes-Based Agreements Work for Weight Loss Drugs? & more

ByMiranda Schmalfuhs

September 5th 2024

Pharma Pulse 9/4/24: How Do You Change a Chatbot’s Mind? Understanding the Current State of M&A & more

ByMiranda Schmalfuhs

September 4th 2024

The latest news for pharma industry insiders.

Pharma Pulse 9/3/24: CrowdStrike VP to Testify on IT Outage, Embracing FSPs & more

ByMiranda Schmalfuhs

September 3rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/30/24: Medication Mistakes Pharmacists Want You to Stop Making, Express Scripts to Remove Humira & more

ByMiranda Schmalfuhs

August 30th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/29/24: Talkspace and PTPA Join Forces, Digital Medicines Information & more

ByMiranda Schmalfuhs

August 29th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/28/24: AI Regulation Is Coming, A Case for Payer Engagement/Participation in Clinical Research & more

ByMiranda Schmalfuhs

August 28th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/27/24: Inside a Love-Hate Relationship With ChatGPT, Virtual Care's Role in Behavioral Health & more

ByMiranda Schmalfuhs

August 27th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/26/24: BioAge Appoints Former GSK CEO to Board of Directors, Addressing Challenges to Access & more

ByMiranda Schmalfuhs

August 26th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/23/24: Pfizer/BioNTech FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine, Hidden Obstacles in the Script-to-Therapy Journey & more

ByMiranda Schmalfuhs

August 23rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/22/24: OM1 Appoints New President, Navigating Global Regulatory Hurdles & more

ByMiranda Schmalfuhs

August 22nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/21/24: Choosing the Best Clinical Technology for Your Study, Walmart Launches Autoimmune-Focused Specialty Pharmacies of the Community & more

ByMiranda Schmalfuhs

August 21st 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/20/24: Moderna Announces Free mRNA Course, OpenAI Disrupts Iranian Misinformation Campaign & more

ByMiranda Schmalfuhs

August 20th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/16/24: The Future of Launch Excellence is GenAI, Will Negotiated Drug Prices Actually Save Money? & more

ByMiranda Schmalfuhs

August 16th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/15/24: Ryan Reynolds Announces Parkinson’s Campaign, Tackling Vaccine Hesitancy & more

ByMiranda Schmalfuhs

August 15th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/14/24: Brands Love Influencers...Until Politics Get Involved, Improving Pain Self-Management Among Rural, Older Cancer Patients & more

ByMiranda Schmalfuhs

August 14th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/13/24: How Should Biotechs Strategize for 2025, Pfizer Announces Top-Line Results of ABRYSVO for RSV & more

ByMiranda Schmalfuhs

August 13th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/12/24: Balancing Profitability and Mission, Minority Groups Remain Underrepresented in Vitiligo Trials & more

ByMiranda Schmalfuhs

August 12th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/9/24: Vitamin/Mineral Rich Diets Could Aid Biological Age, LEO Pharma's Patient-Centric Approach & more

ByMiranda Schmalfuhs

August 9th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/8/24: Addressing Maternal Health Disparities and Driving Change, Abacavir Increases Cardiovascular Risk in Patients With HIV & more

ByMiranda Schmalfuhs

August 8th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/7/24: Struggling AI Startups Look for a Bailout from Big Tech, Strategic Market Access Ensures the Right Treatments at the Right Time & more

ByMiranda Schmalfuhs

August 7th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/6/24: Empty Shelves, Urgent Solutions, DocGo and MinXray Launch Mobile X-Ray Program & more

ByMiranda Schmalfuhs

August 6th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/5/24: Understanding IDNs, Medicaid Must Make Crucial Changes to Get Ahead of HIV Epidemic & more

ByMiranda Schmalfuhs

August 5th 2024

The latest news for pharma industry insiders.

Pharma Pulse 8/2/24: Overcoming Challenges to Drive Digital Customer Engagement, Mental Health Leaves of Absence Continue to Proliferate & more

ByMiranda Schmalfuhs

August 2nd 2024

The latest news for pharma industry insiders.

Pharm Pulse 8/1/24: Defining the Health Equity Officer Role, How AI is Revamping the Product Launch & more

ByMiranda Schmalfuhs

August 1st 2024

Pharma Pulse 7/31/24: In the Specialty Drug Spend — Biologics Rule, Big Pharma Rallies and Moves Past Obesity & more

ByMiranda Schmalfuhs

July 31st 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/30/24: The Doctor Will See You Now, But AI May Be Listening In...The Importance of Genomic Sequencing in the Battle Against HIV in South Africa & more

ByMiranda Schmalfuhs

July 30th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/29/24: Fighting the Drop in Vaccination Rates, OpenAI Takes Aim at Google & more

ByMiranda Schmalfuhs

July 29th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/26/24: Talent Management Strategies for Post-Milestone Growth, Dispensing Medication for Muslims & more

ByMiranda Schmalfuhs

July 26th 2024

The latest news for pharma industry insiders.

Pharma Pulse 7/25/24: CrowdStrike Explains What Went Wrong Days After Global Tech Outage, The Future of Biosimilars & more

ByMiranda Schmalfuhs

July 25th 2024

The latest news for pharma industry insiders.

Miranda Schmalfuhs

Articles by Miranda Schmalfuhs

Pharma Pulse 9/6/24: Validating COAs, Simplified HIV Treatments Can Lead to Lower Healthcare Costs & more

Pharma Pulse 9/5/24: FDA Wants Safer Cancer Drugs, Can Outcomes-Based Agreements Work for Weight Loss Drugs? & more

Pharma Pulse 9/4/24: How Do You Change a Chatbot’s Mind? Understanding the Current State of M&A & more

Pharma Pulse 9/3/24: CrowdStrike VP to Testify on IT Outage, Embracing FSPs & more

Pharma Pulse 8/30/24: Medication Mistakes Pharmacists Want You to Stop Making, Express Scripts to Remove Humira & more

Pharma Pulse 8/29/24: Talkspace and PTPA Join Forces, Digital Medicines Information & more

Pharma Pulse 8/28/24: AI Regulation Is Coming, A Case for Payer Engagement/Participation in Clinical Research & more

Pharma Pulse 8/27/24: Inside a Love-Hate Relationship With ChatGPT, Virtual Care's Role in Behavioral Health & more

Pharma Pulse 8/26/24: BioAge Appoints Former GSK CEO to Board of Directors, Addressing Challenges to Access & more

Pharma Pulse 8/23/24: Pfizer/BioNTech FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine, Hidden Obstacles in the Script-to-Therapy Journey & more

Pharma Pulse 8/22/24: OM1 Appoints New President, Navigating Global Regulatory Hurdles & more

Pharma Pulse 8/21/24: Choosing the Best Clinical Technology for Your Study, Walmart Launches Autoimmune-Focused Specialty Pharmacies of the Community & more

Pharma Pulse 8/20/24: Moderna Announces Free mRNA Course, OpenAI Disrupts Iranian Misinformation Campaign & more

Pharma Pulse 8/16/24: The Future of Launch Excellence is GenAI, Will Negotiated Drug Prices Actually Save Money? & more

Pharma Pulse 8/15/24: Ryan Reynolds Announces Parkinson’s Campaign, Tackling Vaccine Hesitancy & more

Pharma Pulse 8/14/24: Brands Love Influencers...Until Politics Get Involved, Improving Pain Self-Management Among Rural, Older Cancer Patients & more

Pharma Pulse 8/13/24: How Should Biotechs Strategize for 2025, Pfizer Announces Top-Line Results of ABRYSVO for RSV & more

Pharma Pulse 8/12/24: Balancing Profitability and Mission, Minority Groups Remain Underrepresented in Vitiligo Trials & more

Pharma Pulse 8/9/24: Vitamin/Mineral Rich Diets Could Aid Biological Age, LEO Pharma's Patient-Centric Approach & more

Pharma Pulse 8/8/24: Addressing Maternal Health Disparities and Driving Change, Abacavir Increases Cardiovascular Risk in Patients With HIV & more

Pharma Pulse 8/7/24: Struggling AI Startups Look for a Bailout from Big Tech, Strategic Market Access Ensures the Right Treatments at the Right Time & more

Pharma Pulse 8/6/24: Empty Shelves, Urgent Solutions, DocGo and MinXray Launch Mobile X-Ray Program & more

Pharma Pulse 8/5/24: Understanding IDNs, Medicaid Must Make Crucial Changes to Get Ahead of HIV Epidemic & more

Pharma Pulse 8/2/24: Overcoming Challenges to Drive Digital Customer Engagement, Mental Health Leaves of Absence Continue to Proliferate & more

Pharm Pulse 8/1/24: Defining the Health Equity Officer Role, How AI is Revamping the Product Launch & more

Pharma Pulse 7/31/24: In the Specialty Drug Spend — Biologics Rule, Big Pharma Rallies and Moves Past Obesity & more

Pharma Pulse 7/30/24: The Doctor Will See You Now, But AI May Be Listening In...The Importance of Genomic Sequencing in the Battle Against HIV in South Africa & more

Pharma Pulse 7/29/24: Fighting the Drop in Vaccination Rates, OpenAI Takes Aim at Google & more

Pharma Pulse 7/26/24: Talent Management Strategies for Post-Milestone Growth, Dispensing Medication for Muslims & more

Pharma Pulse 7/25/24: CrowdStrike Explains What Went Wrong Days After Global Tech Outage, The Future of Biosimilars & more

Trending on Pharmaceutical Commerce

Reducing HIPAA Breaches